Circio has completed a directed share issue, or “private placement,” raising gross proceeds of approximately NOK 250 million (US$26.3 million). The significantly oversubscribed financing represents more than 23 million offer shares, each at a price of NOK 10.80 (US$1.13). An announcement of the completed private placement mentioned a “limited group of new potential investors” in Circio. However, these have not been publicly specified by name. Circio’s Work to Date Circio is a biotechnol...